Nikolaj heads up our healthcare and life sciences service and holds a PhD from the University of Southern Denmark, where he is still a Research Fellow.
He advises patient organisations, pharmaceutical companies, industry associations, and public sector clients. He does so with advice based on quantitative economic evidence, providing clear stories on the societal and business impact of innovative treatments and regulatory changes.
Nikolaj is an expert on health economics, real-world evidence (RWE), burden of illness studies, value of medicine studies, health economic outcomes research (HEOR), and quality of life (QoL) measurement.
